Please assess the completion status of the following clinical trial:

Trial Title: A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Woman with histologically confirmed breast cancer who underwent lumpectomy and requires adjuvant radiation therapy with 2 Gy/fx to a total dose of 50 Gy.~2. Women who received neoadjuvant or adjuvant chemotherapy are eligible for the study. Three weeks is the minimal interval between chemotherapy and start of radiation therapy.~3. Patient able to understand the study designed and cooperate with instructions of use.~4. Patient able to sign informed consent~Exclusion Criteria:~1. Woman with lactose allergy (lactose intolerance are eligible)~2. Woman with known connective tissue disorder~3. Woman with uncontrolled diabetes~4. Patients receiving radiation protocol with 2.64 Gy/fx or 1.8 Gy/fx~5. Woman who is unable to sign an informed consent

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Breast cancer patient receiving RT (Type: None): Total dose:2Gy/Fx

Based on this trial design, predict the completion outcome and termination type (if applicable).